Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists

Authors :: Burger, D.M.
Arends, J.E.
Jacobs, B.S.
Elst-Laurijsen, D.H. van
Kanter, C.T.M.M. de
Maarseveen, E.M. van
Verwey-van Wissen, C.P.W.G.M.
Hoepelman, A.I.
Burger, D.M.
Arends, J.E.
Jacobs, B.S.
Elst-Laurijsen, D.H. van
Kanter, C.T.M.M. de
Maarseveen, E.M. van
Verwey-van Wissen, C.P.W.G.M.
Hoepelman, A.I.
Source :: International Journal of Antimicrobial Agents; 86; 88; 0924-8579; 1; 44; ~International Journal of Antimicrobial Agents~86~88~~~0924-8579~1~44~~
Publication Year :: 2014
Abstract: Item does not contain fulltext

Database :: OAIster
Journal :: International Journal of Antimicrobial Agents; 86; 88; 0924-8579; 1; 44; ~International Journal of Antimicrobial Agents~86~88~~~0924-8579~1~44~~
Publication Type :: Electronic Resource
Accession number :: edsoai.on1284094772
Document Type :: Electronic Resource

Tools